SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 4.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 60.6. According to RSI analysis, sunpharma is technically strong. 9.0 SUNPHARMA RSI Chart
MACD (?) MACD: 11.1 and Signal Line: 11.3. According to MACD analysis, a bearish crossover just happend and it's a negative signal. 0.0 SUNPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sunpharma is facing resistance from it's 200-day simple moving average at 719.7948 and support level is at 692. 7.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, sunpharma is facing resistance from it's 200-day exponential moving average at 713.0964 and support level is at 692. 2.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.738. 5.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 687.9659 and 675.275. Resistance level is 729.05. 6.5 SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 15.4 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 24.5 which means SUNPHARMA is in a trading range and there is no trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
March 24, 2017
Open Price 703.5
High Price 709.65
Low Price 700.2
Close Price 703.9
Absolute Change 0.75
Percentage Change 0.107%
Weekly Change -0.509%
Monthly Change 5%
Yearly Change -15.8%
52-week high 854.95
52-week low 571.9
Corporate Actions
ExDate Purpose
September 08, 2016 AGM/DIV-RE 1/- PER SHARE
July 14, 2016 BUY BACK
October 21, 2015 AGM/DIV-RS 3 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.598
Confidence in Beta1.84%
Market Capital Rs. 169408.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 8.9
TTM Price-to-Earnings (P/E) Ratio 79.1
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 24 March 2017: Deliverable Quantity:7.01e+05 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 24 March 2017: Daily Volatility:0.2828 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 24 March 2017: PCR_OI:0.445 PCR:0.403 NA SUNPHARMA PCR Chart
Premium (?) 24 March 2017 Premium: 1.15 Futures OI:24953600.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 24 March 2017: Price:703.9 Put with maximum OI:700.0 Call with maximum OI:700.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
March 30, 2017 705.05 24953600.0 4582.0 7311.0 703.9
April 27, 2017 709.25 3999800.0 1211.0 3657.0 703.9
May 25, 2017 709.5 37100.0 4.0 4.0 703.9


March 24, 2017 SPress ReleaseSun Pharmaceuticals Industries Limited has informed the Exchange regarding a press release dated March 24, 2017, titled "Almirall and Sun Pharma Announce Regulatory Filing of Tildrakizumab in Europe".
March 23, 2017 SDisclosure under SEBI Takeover RegulationsShanghvi Finance Private Limited has submitted to the Exchange, vide its letter dated March 22, 2017 a copy of disclosures under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 27, 2017 February 14, 2017 TResultsTo consider and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
October 25, 2016 November 10, 2016 TResults/OthersTo transact, interalia, the following business:
See all Board Meetings

SUNPHARMA is part of...

Index Weightage

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 690.1 Rs. 695.1 Rs. 699.5 Rs. 704.6 Rs. 709 Rs. 714 Rs. 718.4